Targeting the kappa opioid receptor with an agonist is a new pharmacy strategy for treating moderate to severe CKD-associated ...

Zen types will tell you to accept the itch, to meditate on it, as you might do if you were in pain. These people have no idea ...

This treatment may be given to patients whose ... No one knows how unbearable chronic itching is until you go through it,' he adds. Around one in six (17 per cent of us) is plagued by a ...

Published reports on placebo-controlled clinical trials and other studies investigating the use of pure opioid antagonists for the prevention and treatment of opioid-induced pruritus (OIP ...

Current uremic pruritus treatments, including antihistamines, gabapentin, moisturizer creams, and capsaicin creams, provide only limited relief. Cannabinoids have various mechanisms that might ...

Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease statusConfirmatory data to ...

"Severe pruritus and the unpredictable occurrence ... data from the ongoing ASSURE-CRU study showed some improvement in the ...

Gill Rich was 50 when she was diagnosed with a rare, chronic liver disease that left her severely fatigued When Gill Rich ...

Add-on dupilumab (Dupixent) significantly reduced itching and urticaria in patients with chronic spontaneous urticaria (CSU) ...

Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved ...

showing treatment with Dupixent resulted in a nearly 50% reduction in itch and urticaria activity scores compared to placebo More than 300,000 people in the US suffer from chronic spontaneous ...